09989.HK
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 3.94
+1.42%Forward multiples
Based on analyst estimates
- P/E forward
- 33.54x
- P/E 2026E
- 7.96x
- P/E 2027E
- 7.52x
- P/E 2028E
- 6.83x
- P/S forward
- 4.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.97x
- PEG TTM
- —
- Price / book
- 0.41x
- Price / sales
- 0.94x
- Price / cash flow
- 3.28x
Enterprise value
- Enterprise value
- HKD 5.1B
- EV / sales
- 0.82x
- EV / EBITDA
- 7.83x
- EV / EBIT
- 22.47x
- Market cap
- HKD 5.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026